ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

Frederick RFP Held Up; NCI Probably Will Reject Any Further Delay

October 15, 1976

In Brief: Obey Was Right- Tests On 70 Chemical Would Have Been Aborted Under NCI Budget

July 20, 1979

Breast Cancer Treatment Studies Need Standard Definitions – Carbone

May 10, 1974

For Frederick, Unseat Program Resources Inc.

March 3, 1995

Defying critics, von Eschenbach describes hands-on role at NCI while running FDA. NCI is unified behind 2015 goal, he says.

December 9, 2005

DCT’s Experimental Therapeutic Program Outlined to Board

May 2, 1975